Mode of action of anticancer peptides (ACPs) from amphibian origin

Christopher Oelkrug1, Martin Hartke2, Andreas Schubert2

  • 1Fraunhofer Institute for Cell Therapy and Immunology (IZI), Leipzig, Germany christopher.oelkrug@izi.fraunhofer.de.

Anticancer Research
|February 11, 2015
PubMed

Insights

Anticancer peptides (ACPs), derived from natural sources like frog secretions, show promise for targeting cancer cells. These peptides offer a novel therapeutic strategy with potential for reduced side effects and drug resistance.

Area of Science:

  • Biochemistry
  • Oncology
  • Peptide Science

Background:

  • Cancer remains a leading global cause of death, necessitating novel therapeutic strategies.
  • Tumor cells exhibit distinct cellular membrane properties, including an increased net negative charge, compared to normal cells.
  • Antimicrobial peptides (AMPs) possess tumoricidal activity, leading to their classification as anticancer peptides (ACPs).

Purpose of the Study:

  • To explore the potential of ACPs as novel anticancer agents.
  • To investigate ACPs derived from natural sources, specifically amphibian skin secretions.
  • To highlight the importance of ACP selectivity, reduced immunogenicity, and favorable pharmacokinetics for therapeutic application.

Main Methods:

  • Review of existing in vitro and in vivo studies on various ACPs.
  • Identification of ACP candidates from amphibian skin secretions, exemplified by Rana chensinensis.
  • Discussion of strategies for ACP modification to enhance efficacy and therapeutic properties.

Main Results:

  • Several hundred ACPs have been investigated for their efficacy against diverse cancer types.
  • Amphibian skin secretions, such as those from Rana chensinensis, are a source of potent ACP candidates.
  • ACPs demonstrate selective targeting of cancer cells, a crucial characteristic for effective therapy.

Conclusions:

  • ACPs represent a promising class of novel anticancer agents with tumoricidal properties.
  • The unique membrane characteristics of cancer cells make them susceptible to ACP-mediated attack.
  • Further research and modification of ACPs are essential to optimize their therapeutic potential and minimize adverse effects.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
15.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
5.1K